Cisplatin and 5-Fluorouracil Boost ICAM-1 in Cancer Cells
Author Information
Author(s): Takizawa K, Kamijo R, Ito D, Hatori M, Sumitani K, Nagumo M
Primary Institution: Second Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University
Hypothesis
The study investigates how cisplatin and 5-fluorouracil synergistically induce ICAM-1 expression in cancer cells.
Conclusion
Cisplatin and 5-fluorouracil induce ICAM-1 expression through a mechanism that does not involve NF-κB.
Supporting Evidence
- Cisplatin and 5-fluorouracil are common anti-tumor agents.
- The expression of ICAM-1 was synergistically induced by the combination of these drugs.
- ICAM-2 and ICAM-3 were not up-regulated by the treatment.
- The induction of ICAM-1 was linked to transcriptional changes in its mRNA.
Takeaway
When two cancer drugs, cisplatin and 5-fluorouracil, are used together, they help cancer cells show a special marker that helps the immune system recognize them better.
Methodology
The study examined the effects of cisplatin and 5-fluorouracil on ICAM-1 expression in squamous cell carcinoma cell lines using flow cytometry and RT-PCR.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website